Navigation Links
CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
Date:6/15/2009

Formulation Development firm CoreRx announces new facility which will add capacity, additional capabilities to growing laboratory in order to meet growing customer demands.

Tampa, FL (Vocus) June 15, 2009 -- CoreRx, Inc. has announced plans to purchase a new facility which will more than triple the company's previous capacity and will accommodate projected growth through 2015.

The 80,000 sq ft building will be remodeled and up-fitted and expanded to ultimately house current staff plus fifty-five new employees. The founders of CoreRx intend to locate the company headquarters at the site, as well as utilize the space for contract manufacturing and formulation research and development. The additional jobs will include expanding the management team, research scientists, research and manufacturing employees, as well as staff for facilities and maintenance. Dr. Todd R. Daviau, President and CEO of CoreRx is hopeful that many of the employees can be hired locally. "I have been very impressed with the assistance that CoreRx is receiving on the state and local level. This is a very important step for our company. We are enthusiastic about the future of CoreRx as well as the positive contribution we hope to make to the community. We wish to express our sincere appreciation to the Greater Tampa Chamber Committee of One Hundred, and all of the County and State officials without whose dedicated efforts this project might not have materialized."

Work on the 80,000 sq ft building will begin in the near future. Plans for the $5Million renovation are being completed at this time. It is hoped that portions of the building can be occupied later this year and the entire expansion can be completed in about 18 months. The average projected wages for the jobs at the facility are projected to be in excess of $65,000.00 per year.

About CoreRx, Inc.
CoreRx™ focuses on
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
2. Next Stage Solutions Announces Three New Financial Services For Emerging Business
3. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
4. Krohne Announces Podcast on Energy Management
5. invivodata Announces ePROficiency 2009 Web Seminar Series
6. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
7. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
8. MEDomics Announces MitoDx(TM), the First NextGen Mitochondrial Genome Diagnostic Test
9. HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University
10. ADVENTRX Pharmaceuticals Announces Financing
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
(Date:11/27/2009)...sed blue dye test alternative is helping bring c...one step closer for pharma-companies. It is a non-...veloped by Sepha for use with blister packs and ... global pharma-companies such as Sanofi-Avenis and...oductivity improvements on the packaging line. B...
(Date:11/25/2009)...r to Speak at Economic Club of Canada , ..., 2009 -- Ambassador to Speak at Economic Club of ...dor for International Investment, and Chairman and...graphy of David Appia go to www.investinfrance.or...meet with press to discuss recent pro-business ini...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...anolMarketAnalysisandForecaststo2013 ,, http:...Market-Analysis-and-Forecasts-to-2013.html ,, ..., Summary ,, Thereportprovidesdetailedanal...razilbioethanolmarketinparticular.Italsohelpsinana...
(Date:11/24/2009)...r to also Visit Detroit , ...a, French Ambassador for International Investment,...cy, , , , ,What: Ambassador Appia is available to...itiatives adopted by France to further develop the...vation and development., , ,When: Available for In...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9
...is, Inc., a leading,developer of clean technology ...irectors have been named to the company,s Board of...h.D., Vice President of Innovation and,Chemicals T... Dutch Shell,plc and Dennis Wolf, Executive Vice P...abase company., "Our new directors bring valuable...
...era,Corporation (Nasdaq: GENR ) today announced t...Officer of Genaera, is scheduled to present at the...he presentation is part of an,RBC Capital Markets,...d,"The Pharmaceutical Sweet Spot: Diabetes & Obesi...December 13 at 10:00 a.m. ET., This panel presen...
... 50 mg/Day Dose for PRISTIQ for the ...VILLE, Pa., Dec. 12 Wyeth,Pharmaceuticals, a divi...rom,two Phase 3 clinical studies of PRISTIQ(TM) (d...inephrine reuptake inhibitor (SNRI), showed,that a...STIQ for the,treatment of major depressive disorde...
Other Biology Technology:Rothwell, Wolf Elected to Codexis Board 2Rothwell, Wolf Elected to Codexis Board 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
(Date:11/24/2009)...nger and the American College of Medical Toxicolog...n the publication of the Journal of Medical Toxic...ginning in March 2010. It was previously publishe...e Journal of Medical Toxicology , an internationa...g the science and practice of medical toxicology. ...
(Date:11/24/2009)...TON ROUGE Antarctica has long held secrets of the...il recently, there has been very little informatio...h miles of ice for millions of years. Now, a team ...SU have been funded to the tune of $10 million do...to get to the bottom of things literally. These s...
Breaking Biology News(10 mins):A coating for life 2Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 1Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 2Merck Schering Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second and Third Line Therapy Since Last Years Analysis of Dyslipidem 13527 3ProCure and INTEGRIS Choose Elekta for Proton Therapy and Cancer Centers 54310 1ProCure and INTEGRIS Choose Elekta for Proton Therapy and Cancer Centers 54310 2ProCure and INTEGRIS Choose Elekta for Proton Therapy and Cancer Centers 54310 3ProCure and INTEGRIS Choose Elekta for Proton Therapy and Cancer Centers 54310 4Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2
...John Smol has been named as one of the 2008 Enviro...an Geographical Society. His half-brother, biologi... which is one of Canada,s most prestigious in the ...mportance of the brothers, scientific work to Cana...inger book series Developments in Paleoenvironment...
...if., June 2 Atmel(R) Corporation (Nasdaq:,ATML), ...echnology and,solutions, announced today that its ... selected by Rise Computer, Inc. for its RX5622 LC...CD PC during 2008 Computex in,Taipei, Taiwan., At...hances consumer,friendliness in the RX5622 LCD PC ...
... Penn State scientists has discovered a new ultra-...re than 120,000 years within the ice of a Greenlan...roorganism,s ability to persist in this low-temper...-poor habitat makes it particularly useful for stu...ty of extreme environments on Earth and possibly e...
Other Biology News:Atmel's FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security 2Atmel's FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security 3A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice 2
Alexa Fluor 350/488/594 Filter Set (Semrock Brightline) *mounted* *Zeiss Axio AF from Molecular Probes (Invitrogen)
Custom Conjugation Services from SoluLink
TMA Foresight from PREMIER Biosoft International from PREMIER Biosoft International
...upply, 1. 3500 V, 400 mA, 200 W maximum.Constant v...ar voltage ramp modes.Linear voltage ramp mode bri...quickly without danger of overheating.Volt-hour an... in gel thickness, sample ionic strength, and temp...
Biology Products: